Mini Review
Published on 03 Jun 2024
Development of liquid biopsy in detection and screening of pancreatic cancer
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Frontiers in Oncology
doi 10.3389/fonc.2024.1415260
Type at least 3 characters
767 articles
Articles
Original Research
Accepted on 31 May 2024
Integrating Metabolic Profiling of Pancreatic Juice with Transcriptomic Analysis of Pancreatic Cancer Tissue Identifies Distinct Clinical Subgroups
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Frontiers in Oncology
doi 10.3389/fonc.2024.1405612
Methods
Accepted on 31 May 2024
Roadmap for providing and leveraging annotated data by cytologists in the PDAC domain as open data: Support for AI-based Pathology Image Analysis Development and Data Utilization Strategies
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Frontiers in Oncology
doi 10.3389/fonc.2024.1346237
Original Research
Published on 30 May 2024
Guiding post-pancreaticoduodenectomy interventions for pancreatic cancer patients utilizing decision tree models
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Frontiers in Oncology
doi 10.3389/fonc.2024.1399297
- 198 views
Review
Accepted on 28 May 2024
Undifferentiated carcinoma with osteoclastlike giant cells of pancreas: A narrative review
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Frontiers in Oncology
doi 10.3389/fonc.2024.1409197
Correction
Accepted on 28 May 2024
Correction: {Advanced lung cancer inflammation index predicts survival outcomes of hepatocellular carcinoma patients receiving immunotherapy}
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Frontiers in Oncology
doi 10.3389/fonc.2024.1431058
Original Research
Accepted on 24 May 2024
Safety and efficacy of Holmium-166 selective internal radiotherapy of primary and secondary liver cancer confirmed by real-world data
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Frontiers in Oncology
doi 10.3389/fonc.2024.1404621
Original Research
Published on 24 May 2024
Development and validation of nomogram to predict overall survival and disease-free survival after surgical resection in elderly patients with hepatocellular carcinoma
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Frontiers in Oncology
doi 10.3389/fonc.2024.1395740
- 168 views
Original Research
Accepted on 23 May 2024
Prognostic implications of preoperative, postoperative, and dynamic changes of alpha-fetoprotein and des-gamma (Îł)-carboxy prothrombin expression pattern for hepatocellular carcinoma after hepatic resection: a multicenter observational study
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Frontiers in Oncology
doi 10.3389/fonc.2024.1425292
Correction
Published on 22 May 2024
Corrigendum: Fat fraction quantification with MRI estimates tumor proliferation of hepatocellular carcinoma
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Frontiers in Oncology
doi 10.3389/fonc.2024.1418905
- 111 views
Review
Published on 21 May 2024
The role of living donor liver transplantation in treating intrahepatic cholangiocarcinoma
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Frontiers in Oncology
doi 10.3389/fonc.2024.1404683
- 203 views
Original Research
Published on 21 May 2024
Interleukin-41: a novel serum marker for the diagnosis of alpha-fetoprotein-negative hepatocellular carcinoma
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Frontiers in Oncology
doi 10.3389/fonc.2024.1408584
- 254 views
Original Research
Published on 17 May 2024
Novel immune classification based on machine learning of pathological images predicts early recurrence of hepatocellular carcinoma
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Frontiers in Oncology
doi 10.3389/fonc.2024.1391486
- 187 views
Case Report
Published on 16 May 2024
Hepatic arterial infusion chemotherapy with implantable arterial access port for advanced-stage hepatocellular carcinoma: a case report
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Frontiers in Oncology
doi 10.3389/fonc.2024.1401882
- 282 views
Original Research
Published on 16 May 2024
The hepatocellular carcinoma risk in patients with HBV-related cirrhosis: a competing risk nomogram based on a 4-year retrospective cohort study
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Frontiers in Oncology
doi 10.3389/fonc.2024.1398968
- 268 views
Hypothesis and Theory
Published on 16 May 2024
Long-term clinical outcomes of [177Lu]Lu-DOTATATE in patients with metastatic neuroendocrine tumors
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
![Long-term clinical outcomes of [177Lu]Lu-DOTATATE in patients with metastatic neuroendocrine tumors](https://www.frontiersin.org/files/myhome article library/1393317/1393317_Thumb_400.jpg)
Frontiers in Oncology
doi 10.3389/fonc.2024.1393317
- 287 views